多支冠状动脉疾病患者的血运重建策略与生存
该前瞻性以色列全国注册研究纳入1064例左主干或累及前降支近段/中段的2-3支冠脉病变患者,55%接受经皮冠状动脉介入治疗(PCI)、45%接受冠状动脉旁路移植术(CABG),随访30个月。SYNTAX评分是选择血运重建策略的主要独立预测因素;术后8个月内PCI死亡风险较低,此后CABG与显著生存获益相关。
要点
- SYNTAX评分每增加1分,转诊CABG的可能性独立增加9%(p < 0.001)。
- 慢性肾功能衰竭(OR 2.43;p = 0.001)和既往心肌梗死(OR 1.7;p = 0.024)与转诊PCI而非CABG相关。
- 术后8个月内PCI死亡风险较低,此后CABG与显著生存获益相关。
核心结论
- 真实世界多支冠状动脉疾病患者的血运重建策略与现行指南一致性良好。
- SYNTAX评分是与血运重建策略选择相关的主要独立预测因素。
- 血运重建策略与长期生存之间的时间依赖性关联应纳入该人群的风险评估。
研究设计与样本
- 前瞻性全国注册研究,连续纳入左主干或累及前降支近段/中段的2-3支冠状动脉疾病患者,随访30个月。
主要发现
- 注册共纳入1064例患者,55%接受PCI,45%接受CABG。
- 慢性肾功能衰竭(OR 2.43;p = 0.001)和既往心肌梗死(OR 1.7;p = 0.024)与转诊PCI而非CABG相关。
- 男性(OR 2.27;p < 0.001)、既往阿司匹林治疗(OR 1.72;p = 0.005)、糖尿病(OR 1.51;p = 0.007)、3支冠状动脉疾病(OR 3.45;p < 0.001)和SYNTAX评分大于32(OR 10.0;p < 0.001)与转诊CABG而非PCI相关。
- SYNTAX评分每增加1分,转诊CABG的可能性独立增加9%(p < 0.001)。
- 生存分析显示,术后8个月内PCI患者死亡风险较低,此后CABG与显著生存获益相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We sought to assess real-world implementation of the guidelines in patients with multivessel coronary artery disease (CAD) using a prospective national registry in Israel. METHODS: All consecutive patients with left main or 2- to 3-vessel CAD involving the proximal or mid left anterior descending artery were enrolled in a dedicated multicenter registry. Patients were managed at the discretion of the treating team at each hospital and were followed for 30 months. RESULTS: This registry included 1,064 patients, 55% treated with percutaneous coronary intervention (PCI) and 45% with coronary artery bypass surgery (CABG). Multivariate logistic regression analysis showed that chronic renal failure (odds ratio [OR], 2.43; p = 0.001) and prior myocardial infarction (OR, 1.7; p = 0.024) were associated with referral to PCI versus CABG, whereas male gender (OR, 2.27; p < 0.001), prior aspirin treatment (OR, 1.72; p = 0.005), diabetes mellitus (OR, 1.51; p = 0.007), 3-vessel CAD (OR, 3.45; p < 0.001) and SYNTAX score (SS) greater than 32 (OR, 10.0; p < 0.001) were associated with referral to CABG versus PCI. Each point increment in the SS was independently associated with a 9% greater likelihood of referral to CABG (p < 0.001). Survival analysis showed that mortality risk was lower among PCI patients less than 8 months after the procedure, and CABG was associated with a significant survival benefit thereafter. CONCLUSIONS: We found good agreement with current guidelines regarding revascularization strategies in real-world patients with multivessel CAD. The SS was the main independent predictor associated with the choice of revascularization strategy. The time-dependent association between revascularization strategy and long-term survival should be incorporated in the risk assessment of this population.
引用
- Fink N, Nikolsky E, Assali A, et al. Revascularization Strategies and Survival in Patients With Multivessel Coronary Artery Disease. Ann Thorac Surg. 2018. PMID: 30267693. doi:10.1016/j.athoracsur.2018.07.070
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。